GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » RIV Capital Inc (XCNQ:RIV) » Definitions » Earnings Yield (Joel Greenblatt) %
中文

RIV Capital (XCNQ:RIV) Earnings Yield (Joel Greenblatt) % : -71.43% (As of Sep. 2023)


View and export this data going back to 2018. Start your Free Trial

What is RIV Capital Earnings Yield (Joel Greenblatt) %?

RIV Capital's Enterprise Value for the quarter that ended in Sep. 2023 was C$69.34 Mil. RIV Capital's EBIT for the trailing twelve months (TTM) ended in Sep. 2023 was C$-49.43 Mil. RIV Capital's Earnings Yield (Joel Greenblatt) for the quarter that ended in Sep. 2023 was -71.43%.

The historical rank and industry rank for RIV Capital's Earnings Yield (Joel Greenblatt) % or its related term are showing as below:

XCNQ:RIV' s Earnings Yield (Joel Greenblatt) % Range Over the Past 10 Years
Min: -27954.59   Med: -27.18   Max: 29230.16
Current: -85.63

During the past 6 years, the highest Earnings Yield (Joel Greenblatt) of RIV Capital was 29230.16%. The lowest was -27954.59%. And the median was -27.18%.

XCNQ:RIV's Earnings Yield (Joel Greenblatt) % is ranked worse than
92.86% of 1093 companies
in the Drug Manufacturers industry
Industry Median: 2.49 vs XCNQ:RIV: -85.63

Joel Greenblatt's definition of earnings yield has the same problems the regular earnings yield does. It does not consider the growth of the company. It only looks at one-year's business operation. For cyclical companies, the earnings yield is usually highest at the peak of the business cycle. But these earnings are rarely sustainable.

A better indicator of the attractiveness of an investment which takes growth into account is the Forward Rate of Return (Yacktman) %. RIV Capital's Forward Rate of Return (Yacktman) % for the quarter that ended in Sep. 2023 was 0.00%. The Forward Rate of Return uses the normalized Free Cash Flow of the past seven years, and considers growth. The forward rate of return can be thought of as the return that investors buying the stock today can expect from it in the future.


RIV Capital Earnings Yield (Joel Greenblatt) % Historical Data

The historical data trend for RIV Capital's Earnings Yield (Joel Greenblatt) % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

RIV Capital Earnings Yield (Joel Greenblatt) % Chart

RIV Capital Annual Data
Trend Mar18 Mar19 Mar20 Mar21 Mar22 Mar23
Earnings Yield (Joel Greenblatt) %
Get a 7-Day Free Trial 1.39 -31.95 -74.63 -68.03 -666.67

RIV Capital Quarterly Data
Dec18 Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23
Earnings Yield (Joel Greenblatt) % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -10,000.00 -2,000.00 -666.67 -454.55 -71.43

Competitive Comparison of RIV Capital's Earnings Yield (Joel Greenblatt) %

For the Drug Manufacturers - Specialty & Generic subindustry, RIV Capital's Earnings Yield (Joel Greenblatt) %, along with its competitors' market caps and Earnings Yield (Joel Greenblatt) % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


RIV Capital's Earnings Yield (Joel Greenblatt) % Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, RIV Capital's Earnings Yield (Joel Greenblatt) % distribution charts can be found below:

* The bar in red indicates where RIV Capital's Earnings Yield (Joel Greenblatt) % falls into.



RIV Capital Earnings Yield (Joel Greenblatt) % Calculation

In his book, The Little That Beat the Market, hedge fund manager Joel Greenblatt defines Earnings Yield as operating income divided by enterprise value.

RIV Capitals Earnings Yield (Joel Greenblatt) for the fiscal year that ended in Mar. 2023 is calculated as

Earnings Yield (Joel Greenblatt)=EBIT/Enterprise Value
=-225.705/33.31704
=-677.45 %

RIV Capital's EBIT for the trailing twelve months (TTM) ended in Sep. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was C$-49.43 Mil.



RIV Capital  (XCNQ:RIV) Earnings Yield (Joel Greenblatt) % Explanation

Joel Greenblatt defines the earnings yield using the above equation because it more accurately reflects the company's profitability relative to its stock price. Items like interest payment and tax etc. are not directly related to the company's operational profitability.

Enterprise Value instead of market cap (share price) is used in the calculation because it is the real price stock and bond investors together pay for the company.


Be Aware

Joel Greenblatt's definition of earnings yield has the same problems the regular earnings yield does. It does not consider the growth of the company. It only looks at one-year's business operation. For cyclical companies, the earnings yield is usually highest at the peak of the business cycle. But these earnings are rarely sustainable.

Forward Rate of Return (Yacktman) % based on Don Yacktman's definition is a better measure of the expected rate of return for a stock.


RIV Capital Earnings Yield (Joel Greenblatt) % Related Terms

Thank you for viewing the detailed overview of RIV Capital's Earnings Yield (Joel Greenblatt) % provided by GuruFocus.com. Please click on the following links to see related term pages.


RIV Capital (XCNQ:RIV) Business Description

Industry
Traded in Other Exchanges
Address
40 King Street West, Suite 2504, Toronto, ON, CAN, M5H 3Y2
RIV Capital Inc is a venture capital investment and operating platform structured to pursue investment opportunities in the cannabis sector. The company has developed an investment ecosystem of complementary cannabis operating companies that represent various segments of the value chain across the cannabis sector. The investments take the form of production-linked royalties, secured debt, newly formed joint ventures, and a variety of equity and equity-linked instruments.